David Lebwohl

Insider Reports History

Entity
Individual
Location
C/O Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge, MA
Signature
James Basta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Lebwohl:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. EVP, Chief Medical Officer Common Stock 93.1K $2.73M $29.38 Mar 1, 2024 Direct
Intellia Therapeutics, Inc. EVP, Chief Medical Officer Restricted Stock Unit 3.19K $76.2K $23.90 Jan 1, 2024 Direct
Intellia Therapeutics, Inc. EVP, Chief Medical Officer Stock Option (right to buy) 55.9K Mar 1, 2024 Direct

Insider Reports Filed by David Lebwohl

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NTLA Intellia Therapeutics, Inc. Mar 1, 2024 2 $0 4 Mar 5, 2024 EVP, Chief Medical Officer
NTLA Intellia Therapeutics, Inc. Jan 3, 2024 1 -$172K 4 Jan 5, 2024 EVP, Chief Medical Officer
NTLA Intellia Therapeutics, Inc. Jan 1, 2024 2 $0 4 Jan 3, 2024 EVP, Chief Medical Officer
NTLA Intellia Therapeutics, Inc. Mar 1, 2023 2 $0 4 Mar 3, 2023 EVP, Chief Medical Officer
NTLA Intellia Therapeutics, Inc. Jan 4, 2023 1 -$95.8K 4 Jan 6, 2023 EVP, Chief Medical Officer
NTLA Intellia Therapeutics, Inc. Jan 1, 2023 2 $0 4 Jan 4, 2023 EVP, Chief Medical Officer
NTLA Intellia Therapeutics, Inc. Mar 1, 2022 1 $0 4/A Mar 4, 2022 EVP, Chief Medical Officer
NTLA Intellia Therapeutics, Inc. Jan 1, 2022 5 -$118K 4 Mar 3, 2022 EVP, Chief Medical Officer
NTLA Intellia Therapeutics, Inc. Nov 5, 2021 6 -$288K 4 Nov 9, 2021 EVP, Chief Medical Officer
NTLA Intellia Therapeutics, Inc. Oct 14, 2021 7 -$278K 4 Oct 15, 2021 EVP, Chief Medical Officer
NTLA Intellia Therapeutics, Inc. Sep 24, 2021 2 $100K 4 Sep 27, 2021 EVP, Chief Medical Officer
NTLA Intellia Therapeutics, Inc. Sep 21, 2021 3 -$329K 4 Sep 23, 2021 EVP, Chief Medical Officer
NTLA Intellia Therapeutics, Inc. Aug 30, 2021 7 -$349K 4 Sep 1, 2021 EVP, Chief Medical Officer
NTLA Intellia Therapeutics, Inc. Aug 9, 2021 3 -$363K 4 Aug 11, 2021 EVP, Chief Medical Officer